COMMUNIQUÉS West-GlobeNewswire

-
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 34 - 2025
29/08/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2025
29/08/2025 -
ALX Oncology to Participate in Upcoming Investor Conferences in September
29/08/2025 -
Renaissance Recovery California Expands to Serve 16 Additional Patients, Meeting Growing Demand for Addiction and Mental Health Treatment
29/08/2025 -
Biohacker Direct Expands Wellness Portfolio with FDA-Registered Hyperbaric Chambers
29/08/2025 -
SRx Health Solutions Cancels an Additional 350,000 Shares, Increasing the Total Number of Shares Canceled to Over 19 Million
29/08/2025 -
Aurora Spine Corporation Announces Record Second Quarter Financial Results
29/08/2025 -
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
29/08/2025 -
Le KFSHRC favorise l’excellence des soins infirmiers grâce à une formation spécialisée
29/08/2025 -
Vaxart Granted Extension by Nasdaq to Regain Compliance
29/08/2025 -
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
29/08/2025 -
CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences
29/08/2025 -
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
29/08/2025 -
Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day
29/08/2025 -
Iovance Biotherapeutics to Present at Upcoming Conferences
29/08/2025 -
Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
29/08/2025 -
Alumis to Participate in Upcoming September Investor Conferences
29/08/2025 -
Arvinas to Participate in Upcoming Investor Conferences
29/08/2025 -
Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025
29/08/2025
Pages